203 related articles for article (PubMed ID: 20432069)
1. Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases.
Bae JH; Schlessinger J
Mol Cells; 2010 May; 29(5):443-8. PubMed ID: 20432069
[TBL] [Abstract][Full Text] [Related]
2. Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ.
Huang Z; Marsiglia WM; Basu Roy U; Rahimi N; Ilghari D; Wang H; Chen H; Gai W; Blais S; Neubert TA; Mansukhani A; Traaseth NJ; Li X; Mohammadi M
Mol Cell; 2016 Jan; 61(1):98-110. PubMed ID: 26687682
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation.
Chen L; Marsiglia WM; Chen H; Katigbak J; Erdjument-Bromage H; Kemble DJ; Fu L; Ma J; Sun G; Zhang Y; Liang G; Neubert TA; Li X; Traaseth NJ; Mohammadi M
Nat Chem Biol; 2020 Mar; 16(3):267-277. PubMed ID: 31959966
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.
Thiel KW; Carpenter G
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19238-43. PubMed ID: 18042729
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for reduced FGFR2 activity in LADD syndrome: Implications for FGFR autoinhibition and activation.
Lew ED; Bae JH; Rohmann E; Wollnik B; Schlessinger J
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19802-7. PubMed ID: 18056630
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic Cysteine Removal Mutations in FGFR Extracellular Domains Stabilize Receptor Dimers and Perturb the TM Dimer Structure.
Sarabipour S; Hristova K
J Mol Biol; 2016 Oct; 428(20):3903-3910. PubMed ID: 27596331
[TBL] [Abstract][Full Text] [Related]
7. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.
Tan L; Wang J; Tanizaki J; Huang Z; Aref AR; Rusan M; Zhu SJ; Zhang Y; Ercan D; Liao RG; Capelletti M; Zhou W; Hur W; Kim N; Sim T; Gaudet S; Barbie DA; Yeh JR; Yun CH; Hammerman PS; Mohammadi M; Jänne PA; Gray NS
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4869-77. PubMed ID: 25349422
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of serine 779 in fibroblast growth factor receptor 1 and 2 by protein kinase C(epsilon) regulates Ras/mitogen-activated protein kinase signaling and neuronal differentiation.
Lonic A; Powell JA; Kong Y; Thomas D; Holien JK; Truong N; Parker MW; Guthridge MA
J Biol Chem; 2013 May; 288(21):14874-85. PubMed ID: 23564461
[TBL] [Abstract][Full Text] [Related]
9. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
Fan YX; Wong L; Deb TB; Johnson GR
J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
[TBL] [Abstract][Full Text] [Related]
10. Unliganded fibroblast growth factor receptor 1 forms density-independent dimers.
Comps-Agrar L; Dunshee DR; Eaton DL; Sonoda J
J Biol Chem; 2015 Oct; 290(40):24166-77. PubMed ID: 26272615
[TBL] [Abstract][Full Text] [Related]
11. Autophosphorylation of EGFR at Y954 Facilitated Homodimerization and Enhanced Downstream Signals.
Thirukkumaran OM; Kluba M; Hofkens J; Mizuno H
Biophys J; 2020 Nov; 119(10):2127-2137. PubMed ID: 33096081
[TBL] [Abstract][Full Text] [Related]
12. Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase.
Spaargaren M; Defize LH; Boonstra J; de Laat SW
J Biol Chem; 1991 Jan; 266(3):1733-9. PubMed ID: 1988447
[TBL] [Abstract][Full Text] [Related]
13. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.
Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A
Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of the mechanism of phosphorylation of a critical autoregulatory tyrosine residue in FGFR1 kinase domain.
Kobashigawa Y; Amano S; Yokogawa M; Kumeta H; Morioka H; Inouye M; Schlessinger J; Inagaki F
Genes Cells; 2015 Oct; 20(10):860-70. PubMed ID: 26300540
[TBL] [Abstract][Full Text] [Related]
15. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
Monsey J; Shen W; Schlesinger P; Bose R
J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
[TBL] [Abstract][Full Text] [Related]
16. Spatio-temporally precise activation of engineered receptor tyrosine kinases by light.
Grusch M; Schelch K; Riedler R; Reichhart E; Differ C; Berger W; Inglés-Prieto Á; Janovjak H
EMBO J; 2014 Aug; 33(15):1713-26. PubMed ID: 24986882
[TBL] [Abstract][Full Text] [Related]
17. Transient epidermal growth factor (EGF)-dependent suppression of EGF receptor autophosphorylation during internalization.
McCune BK; Prokop CA; Earp HS
J Biol Chem; 1990 Jun; 265(17):9715-21. PubMed ID: 1693615
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the catalytic activity of the EGF receptor.
Endres NF; Engel K; Das R; Kovacs E; Kuriyan J
Curr Opin Struct Biol; 2011 Dec; 21(6):777-84. PubMed ID: 21868214
[TBL] [Abstract][Full Text] [Related]
19. The EGFR family: not so prototypical receptor tyrosine kinases.
Lemmon MA; Schlessinger J; Ferguson KM
Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a020768. PubMed ID: 24691965
[TBL] [Abstract][Full Text] [Related]
20. Lidocaine inhibits tyrosine kinase activity of the epidermal growth factor receptor and suppresses proliferation of corneal epithelial cells.
Hirata M; Sakaguchi M; Mochida C; Sotozono C; Kageyama K; Kuroda Y; Hirose M
Anesthesiology; 2004 May; 100(5):1206-10. PubMed ID: 15114219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
